SCIENCE. STRATEGY. SOLUTIONS.
Date
Sept 28-29, 2026
Location
Aurika, Mumbai Skycity
ATTENDEES
SPEAKERS
PARTNERS
SCIENTIFIC POSTERS
WORKSHOPS
Expert-led discussions on the latest advancements in peptides and complex generics with interactive Q&A sessions.
Read MoreShowcase of cutting-edge research through interactive poster sessions and networking opportunities.
Read MoreExplore innovative solutions and technologies from leading industry partners and service providers.
Read MoreHands-on workshops and training sessions to build practical skills and knowledge in specialized areas.
Read More
August 7th, 2026
September 20th, 2026
September 28-29, 2026
The Peptides & Complex Generics Symposium (PCG 2026), organized by Mumbai Biocluster and ICT Mumbai, brings together a curated community of industry leaders, researchers, regulators, CDMOs, startups, and investors to address the evolving landscape of next-generation therapeutics.
As a high-impact platform, it features focused discussions across peptides, complex generics, oligonucleotides and advanced therapeutics.
PCG 2026 expands its lens to Oligonucleotide therapeutics, with a stronger focus on GLP-1, advanced delivery systems, and AI-driven drug development.
Be a part of transformative conversations like never before. Connect with key stakeholders, uncover opportunities in emerging therapeutics, and gain insights to translate innovation into real-world solutions.
As the industry shifts from breakthrough science to mass production, PCG 2026 addresses how the Indian ecosystem can accelerate to meet global GLP-1 demand and expanding CDMO ambitions while strictly ensuring GMP compliance, operational excellence, and global trust.
Driving into technical complexities shaping the global therapeutics landscape.
*Subject to Modifications
Where it all Began
Industry leaders Mr. Namit Joshi, Mr. Sudarshan Jain, Mr. Ajit Singh, and Dr. Ratnesh Jain marked the inauguration of PCG 2025.
GLP-1 Plenary Panel: Moderated by Vikas Dandekar (The Economic Times), with Vikrant Shrotriya (Novo Nordisk), Siddharth Mittal (Biocon Ltd.), Winselow Tucker (Eli Lilly India), Dr. Subramanian Narayanaswamy (Dr. Reddy's Laboratories), and Jatin Vimal (Levim Lifetech Pvt. Ltd.).
Plenary Panel: Reimagining India's Pharma Leadership. Moderated by Dr. Ratnesh Jain (Mumbai Biocluster), with Ajit Singh (IPEC India), Bhushan Akshikar (OPPI), Namit Joshi (Pharmexcil), Mehul M. Shah (IDMA), and Dr. Rajiv Desai (IPA).
Market Expo Highlights: A dynamic exhibition space where companies presented cutting-edge solutions and connected with industry stakeholders.
Poster Presentations: Brought together academic and industry research through interactive scientific exchange.
